Share this post:

On Monday, 23 October, Damiano de Felice will join a CPhL Worldwide side-event in Frankfurt to discuss the rise of antimicrobial resistance (AMR). The event, organised by DSM Sinochem Pharmaceuticals, will bring together decision-makers and key representatives of pharmaceutical companies to discuss the roles and responsibilities of the global health stakeholders in addressing AMR.

Damiano will present the Foundation’s forthcoming Antimicrobial Resistance Benchmark, which is the first independently developed framework for evaluating how pharmaceutical companies respond to AMR. It will map the actions of 30 companies against agreed priorities for limiting AMR, structured around three research areas. The AMR Benchmark aims to incentivise and guide pharmaceutical company action on AMR.

Related posts